Cargando…
Evidence following guidelines: Another COVID-19 paradox
Autor principal: | Heymann, Warren R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598361/ https://www.ncbi.nlm.nih.gov/pubmed/33130184 http://dx.doi.org/10.1016/j.jaad.2020.10.070 |
Ejemplares similares
-
Tele-2020
por: Heymann, Warren R.
Publicado: (2020) -
Dermatology patients on biologics and certain other systemic therapies should receive a “booster” messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations
por: Waldman, Reid Alexander, et al.
Publicado: (2021) -
First, and foremost, a physician
por: Schwarzenberger, Kathryn
Publicado: (2021) -
Challenges and lessons from COVID-19: perspectives of a female interventional cardiologist from a developing country
por: Dakhil, Zainab Atiyah
Publicado: (2021) -
Using research findings in my everyday practice: what is good evidence, where do I look, and how can I use it?
por: Hu, Victor H, et al.
Publicado: (2022)